NHSO agrees to 4 'pricey' medicines
The National Health Security Office (NHSO) board recently approved the universal health scheme's coverage of four extra medicines, which were necessary but rather expensive, NHSO deputy chief Netnapis Suchonwanich said on Sunday.
They are: Trastuzumab, prescribed for early-stage breast cancer; Nilotinib, prescribed for chronic myeloid leukemia; Dasatinib, prescribed for chronic myeloid leukemia for patients with resistance to Imatinib and Nilotinib; and Peg-Interferon prescribed for the treatment of hepatitis.
RELATED